SEROTONIN RESPONSE IN SWEET-FOOD CRAVING ALZHEIMERS-DISEASE SUBJECTS

被引：8

作者：

COOPER, JK

MUNGAS, D

机构：

[1] Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California

[2] National Institute on Aging, Bethesda, Maryland, 20892, Bldg. 31

来源：

AGING-CLINICAL AND EXPERIMENTAL RESEARCH | 1992年 / 4卷 / 02期

关键词：

ALZHEIMERS DISEASE; DIETARY BEHAVIOR; FENFLURAMINE; PROLACTIN; SEROTONIN;

D O I：

10.1007/BF03324086

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Abnormal sweet-food craving may occur in subjects with Alzheimer's disease. This behavior may be due to abnormalities in the brain serotonin system. Fenfluramine stimulates the brain serotonin neurosystem, producing an increase in systemic prolactin. Using the fenfluramine stimulation test, brain serotonin system response was evaluated in 12 subjects with probable Alzheimer's disease. The subjects' caregivers completed questionnaires concerning subject food preferences and behaviors. Alzheimer's disease subjects with sweet-food craving were found to. have a significantly higher response to fenfluramine than non sweet-food craving subjects. This preliminary study is limited by small sample size. Allowing for assumptions concerning central nervous system regulatory processes, the data suggest a possible role for the serotonin system in sweet-food craving in Alzheimer's disease.

引用

页码：165 / 169

页数：5

共 34 条

[1] Steele C., Rovner B., Chase G.A., Folstein M., Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease, Am. J. Psychiatry, 147, pp. 1049-1051, (1990)
[2] Swearer J.M., Drachman D.A., O'Donnel B.F., Mitchell A.L., Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity, J. Am. Geriatr. Soc., 36, pp. 784-790, (1988)
[3] Cooper J.K., Mungas D., Weiler P.G., Relation of cognitive status and abnormal behaviors in Alzheimer’s Disease, J. Am. Geriatr. Soc., 38, pp. 867-870, (1990)
[4] Bartus R.T., Den R.L., Beer B., Lyspi A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217, pp. 408-417, (1982)
[5] Palmer A.M., Francis P.T., Benton J.S., Si N.R., Mann D.M.A., Neary D., Snowden J.S., Bowen D.M., Presynaptic serotonergic dysfunction in patients with Alzheimer’s disease, J. Neurochem., 48, pp. 8-15, (1987)
[6] Bowen D.M., Spillane J.A., Curzon G., Meier-Ruge W., White P., Goodhardt M.J., Iwangoff P., Davison A.N., Accelerated aging or selective neuronal loss as an important cause of dementia, Lancet, 1, pp. 11-14, (1979)
[7] Cross A.J., Crow T.J., Johnson J.A., Bloom S.R., Cozsellis J.A.W., Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of Alzheimer type, J. Neurol. Sci., 64, pp. 109-117, (1984)
[8] Palmer A.M., Strattman G.G., Procter A.W., Bowen D.M., Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease, Ann. Neurol., 23, pp. 616-620, (1988)
[9] Vanderwolf C.H., A general role of serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxythryptamine, Brain Res., 504, pp. 192-198, (1989)
[10] Mungas D., Cooper J., Weiler P., Gietzen D., Franzi C., Bernick C., Dietary preference for sweet foods in patients with dementia, J. Am. Geriatr. Soc., 38, pp. 999-1007, (1990)

← 1 2 3 4 →